Insulinomas: Benign Pancreatic Tumors

Insulinomas, classified as uncommon tumors, are predominantly found in the specialized beta cells of the pancreas. Their incidence rate stands at approximately four cases per one million individuals annually. While diagnosing this condition can pose challenges, surgical intervention typically yields positive results and leads to a favorable prognosis.


Understanding Insulinomas

Insulinomas are tumors that develop in the pancreas, with approximately 90% of cases being benign and relatively small, measuring less than two centimeters in diameter. These tumors are responsible for the overproduction of insulin, a hormone that regulates blood sugar levels by lowering them (known as hypoglycemia). Insulinomas are more commonly found in men and typically affect individuals between the ages of 40 and 60.

In a healthy individual, the pancreas produces insulin in response to elevated blood sugar or glucose levels. The insulin helps to normalize blood glucose levels, and once the levels return to normal, the pancreas ceases its production of insulin. However, in the case of insulinomas, the tumors continue to produce insulin, causing blood sugar levels to drop excessively below the normal range.


Symptoms and Signs of Low Blood Sugar

Low blood sugar, also known as hypoglycemia, can manifest through various symptoms and signs. It is important to recognize these indicators to address the condition promptly and prevent further complications. Commonly experienced symptoms include sweating, a pale complexion, a rapid heartbeat, and trembling. As the blood sugar levels continue to drop, individuals may also encounter dizziness, blurred or double vision, confusion, and even aggression. Failure to treat low blood sugar can lead to more severe consequences such as seizures and coma. It is crucial to seek medical attention if blood sugar levels fall below 72 milligrams per deciliter (72mg/dL).

PREV1 of 5